BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1775194)

  • 1. Carrier-mediated outward transport of dopamine from adrenergic varicosities of the vas deferens of reserpine-pretreated rats.
    Langeloh A; Halbrügge T; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):619-22. PubMed ID: 1775194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.
    Russ H; Schömig E; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):286-96. PubMed ID: 1961255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veratridine-induced outward transport of 3H-noradrenaline from adrenergic nerves of the rat vas deferens.
    Bönisch H; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):621-30. PubMed ID: 3444479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active transport of 3H-bretylium in the rat vas deferens in vitro.
    Ross SB; Kelder D
    Acta Physiol Scand; 1976 Jun; 97(2):209-21. PubMed ID: 949007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens.
    Stute N; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):124-32. PubMed ID: 6208488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The accumulation of C14-serotonin in the guinea-pig vas deferens.
    Thoa NB; Eccleston D; Axelrod J
    J Pharmacol Exp Ther; 1969 Sep; 169(1):68-73. PubMed ID: 5804612
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of drugs on the synthesis of noradrenaline in guinea-pig vas deferens.
    Boadle-Biber MC; Roth RH
    Br J Pharmacol; 1972 Dec; 46(4):696-707. PubMed ID: 4655268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat.
    Schömig E; Fischer P; Schönfeld CL; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):502-8. PubMed ID: 2559332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.
    Langeloh A; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):611-20. PubMed ID: 3444478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyldopa abolishes neurally evoked contractions of the vas deferens in vitro.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1979 Apr; 238(2):187-95. PubMed ID: 475507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of adrenergic varicosities to the 3H-noradrenaline-releasing effect of potassium.
    Schönfeld CL; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):520-6. PubMed ID: 1811169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of dopamine and related amines on reserpinized and chronically denervated vasa deferentia of the rat.
    Lafi MA; Leake LD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 89(2):141-6. PubMed ID: 2898988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo.
    Kanzaki A; Akiyama K; Otsuki S
    Brain Res; 1992 Jan; 569(2):181-8. PubMed ID: 1371707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines.
    Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):135-41. PubMed ID: 3010139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal efflux of noradrenaline induced by tris or lithium as substitutes for extracellular sodium.
    Bönisch H; Langeloh A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):13-6. PubMed ID: 3016559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.
    Schömig E; Schönfeld CL; Halbrügge T; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):160-70. PubMed ID: 2234101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postsynaptic effects of p-tyramine and p-octopamine in the prostatic portion of the rat vas deferens.
    Celuch SM; Juorio AV
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):39-46. PubMed ID: 2907098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.